Photodynamic Inactivation of Mycobacterium tuberculosis Using Alluminium Phthalocyanine

Area of Science:

• Biomedical Engineering
• Microbiology
• Photochemistry

Background:

• Tuberculosis remains a significant global health challenge, necessitating novel treatment strategies.
• Photodynamic inactivation (PDI) offers a potential alternative or adjunct therapy for Mycobacterium tuberculosis infections.
• Aluminum phthalocyanine is a photosensitizer investigated for its antimicrobial properties.

Purpose of the Study:

• To determine optimal laser treatment parameters for effective photodynamic inactivation of Mycobacterium tuberculosis.
• To evaluate the efficacy of PDI against both drug-susceptible and drug-resistant strains of M. tuberculosis.
• To establish the relationship between laser energy density and photosensitizer dose for PDI.

Main Methods:

• In vitro experiments using Mycobacterium tuberculosis (H37Rv strain and clinical isolates).
• Incubation of M. tuberculosis with aluminum phthalocyanine (5 μg/ml).
• Photodynamic inactivation using laser irradiation (λ=662 nm) at varying power densities and assessment of mycobacterial survival via CFU assay.

Main Results:

• Photodynamic inactivation demonstrated dose-dependent inhibition and complete cessation of M. tuberculosis growth.
• Effective inactivation was achieved starting from 46.9 J/cm² at 0.01 W and 56.25 J/cm² at 0.1 W.
• Low-intensity laser power PDI was found to be more effective against drug-susceptible M. tuberculosis strains.

Conclusions:

• Optimal laser regimes were identified for effective photodynamic inactivation of M. tuberculosis using aluminum phthalocyanine.
• PDI shows promise as a therapeutic approach against M. tuberculosis, with varying efficacy based on drug susceptibility and laser parameters.
• Further research into PDI parameters could lead to improved tuberculosis treatment strategies.